GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 120 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,705 | -27.7% | 60,875 | -18.1% | 0.03% | -24.4% |
| Q2 2023 | $144,875 | -58.9% | 74,295 | -41.4% | 0.04% | -61.7% |
| Q1 2023 | $352,248 | -21.0% | 126,708 | -2.0% | 0.11% | -28.7% |
| Q4 2022 | $446,044 | +30.8% | 129,288 | -2.7% | 0.15% | +23.0% |
| Q3 2022 | $341,000 | +6.2% | 132,851 | 0.0% | 0.12% | +10.9% |
| Q2 2022 | $321,000 | -54.1% | 132,851 | -21.7% | 0.11% | -43.3% |
| Q1 2022 | $699,000 | +104.4% | 169,736 | +538.6% | 0.19% | +123.0% |
| Q4 2021 | $342,000 | +19.6% | 26,580 | +0.2% | 0.09% | +13.0% |
| Q3 2021 | $286,000 | +18.2% | 26,524 | 0.0% | 0.08% | +18.5% |
| Q2 2021 | $242,000 | -9.7% | 26,524 | -3.2% | 0.06% | -13.3% |
| Q1 2021 | $268,000 | -2.5% | 27,413 | -60.7% | 0.08% | -12.8% |
| Q4 2020 | $275,000 | – | 69,778 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $17,536,000 | 1.82% |
| EcoR1 Capital, LLC | 3,421,287 | $13,480,000 | 0.72% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $8,123,000 | 0.63% |
| BVF INC/IL | 2,695,418 | $10,620,000 | 0.42% |
| Column Group LLC | 869,493 | $3,426,000 | 0.31% |
| Avidity Partners Management LP | 2,122,064 | $8,361,000 | 0.27% |
| Redmile Group, LLC | 3,059,794 | $12,056,000 | 0.15% |
| SkyOak Wealth, LLC | 69,778 | $275,000 | 0.09% |
| Tekla Capital Management LLC | 419,005 | $1,651,000 | 0.06% |
| Blackstone Inc. | 2,567,445 | $10,116,000 | 0.04% |